Ameriprise Financial Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Ameriprise Financial Inc

$364 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $2.97 Million - $3.12 Million	-20,501 Reduced 41.09%	29,388 $4.44 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $485,870 - $853,165	5,844 Added 13.27%	49,889 $7.27 Million
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $24,878 - $32,299	-226 Reduced 0.51%	44,045 $5.22 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $472,520 - $703,498	-4,738 Reduced 9.67%	44,271 $6.1 Million
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $420,804 - $591,339	-4,257 Reduced 7.99%	49,009 $6.81 Million
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $137,809 - $220,016	2,095 Added 4.09%	53,266 $5.17 Million
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $421,068 - $602,981	-6,572 Reduced 11.38%	51,171 $3.5 Million
Q4 2020 Feb 12, 2021	SELL	$65.07 - $98.24 $870,376 - $1.31 Million	-13,376 Reduced 18.81%	57,743 $4.95 Million
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $806,250 - $1.06 Million	-13,656 Reduced 16.11%	71,119 $4.62 Million
Q2 2020 Aug 14, 2020	SELL	$29.01 - $74.23 $159,090 - $407,077	-5,484 Reduced 6.08%	84,775 $6.2 Million
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $572,675 - $1.19 Million	20,817 Added 29.98%	90,259 $3.07 Million
Q4 2019 Feb 14, 2020	BUY	$40.86 - $57.65 $205,525 - $289,979	5,030 Added 7.81%	69,442 $3.78 Million
Q3 2019 Nov 14, 2019	SELL	$37.38 - $49.47 $128,250 - $169,731	-3,431 Reduced 5.06%	64,412 $2.69 Million
Q2 2019 Aug 14, 2019	SELL	$39.79 - $67.01 $410,951 - $692,079	-10,328 Reduced 13.21%	67,843 $2.97 Million
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $1 Million - $1.55 Million	29,072 Added 59.21%	78,171 $4.02 Million
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $403,172 - $581,380	13,552 Added 38.12%	49,099 $1.82 Million
Q3 2018 Nov 14, 2018	BUY	$32.79 - $43.0 $1.17 Million - $1.53 Million	35,547 New	35,547 $1.34 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account